Are You or A Loved One Living with Alzheimer’s Disease? Consider Participating in the ACT-AD Trial

ACT-AD is a Phase 2 Study of an Investigational Drug for the Treatment of Mild to Moderate Alzheimer’s Disease.

About ACT-AD

The ACT-AD trial is evaluating if a new investigational drug (ATH-1017) is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease. ATH-1017 is designed to boost a repair and regenerative pathway for brain cells, promoting brain health and function. ATH-1017 represents a new approach to treat Alzheimer’s disease, potentially targeting the root cause of memory decline by repairing brain cells and rebuilding brain networks.


You or a loved one may be eligible if you:

  • Are between 55 and 85 years of age
  • Have been diagnosed with Alzheimer’s disease
  • Have a reliable support person or caregiver who is willing to participate in study visits, report on daily activities and oversee or help you with taking ATH-1017
  • Study participation and study drug are free to all participants enrolled in the study
  • You may receive a stipend to compensate for time and effort for study participation including meals, travel, etc.

* The safety and efficacy of ATH-1017 for the treatment of mild to moderate Alzheimer’s has not been previously established. Talk to your doctor about participating in Athira’s clinical trials of ATH-1017.

What to Expect

Participating in ACT-AD

The ACT-AD trial is seeking to enroll approximately up to 75 participants with mild to moderate Alzheimer’s disease in the United States and Australia. Qualified participants will be randomly assigned to receive ATH-1017 or placebo. Participation in the study takes about eight months including approximately six months of treatment duration. During the treatment period, you or your caregiver will administer daily subcutaneous injections using the provided prefilled syringes (i.e. small injection under the skin that you can take at home; the injection is prepared and ready for administration).


What is Involved in the Trials?

Study Locations

Additional study site locations coming soon. Check back and enter your zip code for updates.

    Additional study site locations coming soon. Check back and enter your zip code for updates.